Marcinkevičiaus klinika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 9,200 | 13,040 | 16,540 | 13,440 | 17,697 | 34,116 | 37,559 | 30,388 |
| Profit before tax | 1,060 | 8,306 | 624 | 4,084 | -9,225 | -3,193 | -1,191 | - |
| Net profit | 1,060 | 7,913 | 523 | 3,471 | -9,225 | -3,193 | -1,191 | 335 |
| Equity | 2,134 | 7,715 | 8,269 | 11,740 | 2,427 | 494 | -697 | -362 |
| Liabilities | - | - | - | - | 3,963 | 4,572 | 9,599 | 3,670 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 2,233 | 8,717 | 8,845 | 13,099 | 6,390 | 5,066 | 8,902 | 3,308 |
| Total assets | 2,233 | 8,717 | 8,845 | 13,099 | 6,390 | 5,066 | 8,902 | 3,308 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 971 | 1,097 | 1,642 |
| Social insurance contributions | - | - | - | - | - | 1,994 | 3,809 | 1,734 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +135.0% | +41.7% | +26.8% | -18.7% | +31.7% | +92.8% | +10.1% | -19.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 47.5% | 90.8% | 5.9% | 26.5% | -144.4% | -63.0% | -13.4% | 10.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 49.7% | 102.6% | 6.3% | 29.6% | -380.1% | -646.4% | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 11.5% | 60.7% | 3.2% | 25.8% | -52.1% | -9.4% | -3.2% | 1.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 11.5% | 63.7% | 3.8% | 30.4% | -52.1% | -9.4% | -3.2% | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 1.6 | 9.3 | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 9,200 | 13,040 | 16,540 | 13,440 | 5,309 | 8,710 | 10,731 | 9,116 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Marcinkevičiaus klinika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-04-20 | 2026-04-22 | 0.66 |
| 2026-03-29 | 2026-04-02 | 0.58 |
| 2026-03-17 | 2026-03-27 | 0.58 |
| 2026-02-18 | 2026-03-02 | 0.86 |
| 2026-01-22 | 2026-02-03 | 1.51 |
| 2025-12-16 | 2025-12-30 | 280.01 |
| 2025-10-16 | 2025-10-21 | 195.24 |
| 2025-02-10 | 2025-02-10 | 0.15 |
| 2025-01-22 | 2025-02-04 | 0.15 |
| 2023-12-18 | 2023-12-28 | 0.22 |
| 2023-10-17 | 2023-11-05 | 0.25 |
| 2023-05-02 | 2023-05-03 | 130.01 |
| 2023-04-18 | 2023-04-28 | 130.01 |
| 2022-06-16 | 2022-06-20 | 42.77 |
| 2022-03-16 | 2022-04-06 | 40.78 |
Marcinkevičiaus klinika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-01-30 | 2025-02-05 | 0.15 |
| 2024-10-16 | 2024-10-16 | 13.15 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Marcinkeviciaus klinika, MB (code 304229946) is a Small partnership operating in other human health activities n.e.c. In the latest financial year, 2025, the company generated EUR 30.4K in revenue, which was 19.1% lower than in 2024 and 10.9% below the 2023 level. Profitability improved after two loss-making years: net profit reached EUR 335 in 2025, compared with a EUR 1.2K loss in 2024 and a EUR 3.2K loss in 2023. The 2025 profit margin was 1.1%, while earlier years remained negative. The balance sheet remained small and volatile. Total assets amounted to EUR 3.3K in 2025, down from EUR 8.9K in 2024, and liabilities decreased to EUR 3.7K from EUR 9.6K. Equity stayed negative at EUR 362, so capital-based ratios should be interpreted cautiously. Asset turnover was 9.19x, reflecting a relatively high level of revenue against a very small asset base. Revenue per employee was EUR 10.1K and profit per employee EUR 112, indicating limited scale but a return to slight profitability in 2025.